In addition, WSB2 also mediates the degradation of KLF15, result in a transcriptional repression of PDLIM2 and activation of NF-κB signaling pathway to promote development of HCC (Chen et al., 2025). Here, WSB2 is linked to hepatocellular carcinoma.